HIF-1α is a regulator of galectin-3 expression in the intervertebral disc

被引:88
作者
Zeng, Yan [1 ]
Danielson, Keith G.
Albert, Todd J.
Shapiro, Irving M.
Risbud, Makarand V.
机构
[1] Thomas Jefferson Univ, Dept Orthopaed Surg, Philadelphia, PA 19107 USA
[2] Peking Univ Hosp 3, Dept Orthopaed Surg, Beijing, Peoples R China
关键词
intervertebral disc; nucleus pulposus; hypoxia inducible factor-1 alpha; galectin-3; survival factor;
D O I
10.1359/JBMR.070620
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The regulation of galectin-3 expression in skeletal tissues is not completely understood. Our studies indicate that HIF-1 alpha regulates galectin-3 expression by interacting with hypoxia regulatory elements in the promoter region. Finally, we show that galectin-3 serves a prosurvival role in the intervertebral disc. Introduction: Earlier reports indicated that galectin-3 (gal-3) is highly expressed in the epiphyseal growth plate cartilage and the intervertebral disc. Because these skeletal tissues have a limited vascular supply and the cells reside in a low O-2 environment, we determined if the oxemic status modulates gal-3 expression. Materials and Methods: Cells were cultured in normoxia (21% O-2) or hypoxia (2% O-2), and gal-3 expression and promoter activity were evaluated. Interaction of hypoxia inducible factor (HIF)-1 alpha with the gal-3 promoter was confirmed by gel shift and site-directed mutagenesis. Results: There was minimal oxygen-dependent change in HIF-1 alpha levels and no change in gal-3 expression and promoter activity in nucleus pulposus cells. In contrast, hypoxia induced gal-3 mRNA, protein, and promoter activity in HeLa cells and mouse embryonic fibroblasts (MEFs) from HIF-1 alpha wildtype but not HIF-1-null mice. To evaluate the importance of HIF-1 in regulation of gal-3 expression, we overexpressed HIF-1 alpha or constitutively active-HIF-1 alpha in null MEF. An increase in gal-3 promoter activity was observed in both normoxia and hypoxia. Similarly, suppression of HIF-1 alpha in nucleus pulposus cells, and wildtype MEF, using siRNA and pharmacological inhibitors resulted in suppression of gal-3 promoter activity and mRNA levels. Analysis of the gal-3 promoter indicated that it contained two hypoxia response elements (HREs). Gel-shift and chromatin immunoprecipitation analysis confirmed that there was binding of HIF-1 alpha to the gal-3 HRE. Furthermore, site-directed mutagenesis of HRE completely blocked hypoxic induction of gal-3 promoter activity. In nucleus pulposus cells, suppression of gal-3 expression promoted FasL-mediated apoptosis. Conclusions: Together, these studies showed that gal-3 is a HIF-1-regulated lectin that plays an important role in nucleus pulposus cell survival.
引用
收藏
页码:1851 / 1861
页数:11
相关论文
共 50 条
  • [21] Galectin-3 is a regulator of metaflammation in adipose tissue and pancreatic islets
    Pejnovic, Nada N.
    Pantic, Jelena M.
    Jovanovic, Ivan P.
    Radosavljevic, Gordana D.
    Djukic, Aleksandar Lj
    Arsenijevic, Nebojsa N.
    Lukic, Miodrag L.
    ADIPOCYTE, 2013, 2 (04) : 266 - 271
  • [22] Hydrocortisone and dexamethasone affect galectin-3 expression
    Dabelic, S
    Flögel, M
    Dumic, J
    PERIODICUM BIOLOGORUM, 2005, 107 (02) : 175 - 181
  • [23] Prognostic value of galectin-1 and galectin-3 expression in localized urothelial bladder cancer
    Zhu, Jason
    Livasy, Chad
    Donahue, Erin E.
    Symanowski, James T.
    Grigg, Claud M.
    Brown, Landon C.
    Matulay, Justin T.
    Kearns, James T.
    Raghavan, Derek
    Burgess, Earle F.
    Clark, Peter E.
    TRANSLATIONAL ANDROLOGY AND UROLOGY, 2023, 12 (02) : 228 - +
  • [24] Expression of galectin-3 and its regulation in the testes
    Deschildre, Catherine
    Ji, Jing Wei
    Chater, Sonia
    Dacheux, Francoise
    Selva, Jacqueline
    Albert, Martine
    Bailly, Marc
    Hatey, Francois
    Benahmed, Mohamed
    INTERNATIONAL JOURNAL OF ANDROLOGY, 2007, 30 (01): : 28 - 40
  • [25] Expression of Galectin-3 in Pancreatic Ductal Adenocarcinoma
    Gaida, Matthias M.
    Bach, Sylvia T.
    Guenther, Frank
    Baseras, Billur
    Tschaharganeh, Darjus F.
    Welsch, Thilo
    Felix, Klaus
    Bergmann, Frank
    Haensch, Gertrud M.
    Wente, Moritz N.
    PATHOLOGY & ONCOLOGY RESEARCH, 2012, 18 (02) : 299 - 307
  • [26] Curcumin -: A potent inhibitor of galectin-3 expression
    Dumic, J
    Dabelic, S
    Flögel, M
    FOOD TECHNOLOGY AND BIOTECHNOLOGY, 2002, 40 (04) : 281 - 287
  • [27] Expression of antigen tf and galectin-3 in fibroadenoma
    Gallegos I.B.
    Pérez-Campos E.
    Martinez M.
    Mayoral M.A.
    Pérez L.
    Aguilar S.
    Zenteno E.
    Pina M.D.S.
    Hernández P.
    BMC Research Notes, 5 (1)
  • [28] Galectin-1 and galectin-3 expression profiles in classically and alternatively activated human macrophages
    Novak, Ruder
    Dabelic, Sanja
    Dumic, Jerka
    BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS, 2012, 1820 (09): : 1383 - 1390
  • [29] Expression and clinical significance of galectin-3 in osteosarcoma
    Zhou, Xuesong
    Jing, Jie
    Peng, Jing
    Mao, Wen
    Zheng, Yizhou
    Wang, Du
    Wang, Xin
    Liu, Zhiming
    Zhang, Xiangming
    GENE, 2014, 546 (02) : 403 - 407
  • [30] Enhanced expression of Galectin-3 in gestational diabetes
    Heusler, Ishai
    Biron-Shental, Tal
    Farladansky-Gershnabel, Sivan
    Pasternak, Yael
    Kidron, Debora
    Vulih-Shuitsman, Inna
    Einbinder, Yael
    Cohen-Hagai, Keren
    Benchetrit, Sydney
    Zitman-Gal, Tali
    NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES, 2021, 31 (06) : 1791 - 1797